Bruce A. Warden

TL;DR: This review will provide an overview of DOACs and act as a practical reference for clinicians to optimize DOAC use among common challenging scenarios and Topics addressed include appropriate indications, use in patients with specific comorbidities, and cost considerations.

TL;DR: The aim of this review is to provide context to the discovery, history, treatment and current status of PCSK9 and its therapeutic inhibitors and highlight areas of controversy and future directions.

TL;DR: In this paper, the authors describe the real-world follow-up experience of PCSK9i use in a large patient cohort structured to ensure rigor in data collection, analysis, and interpretation.

TL;DR: Pharmacist involvement in medication reconciliation and discharge counseling for HF patients was associated with a significant increase in adherence with the Joint Commission's core measures, a significant reduction in 30-day all-cause readmissions, and a positive effect on patient satisfaction.

TL;DR: This article will review both the pros and cons of today's technologies and their ability to simplify the medication use process, reduce medication errors, improve documentation, improve healthcare costs and increase provider efficiency as relates to the use of antineoplastic therapy throughout the medicationUse process.